Worth reading
72In focus
Scored from 3 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
4815.5555
¥ millionWording
Conditional
How definitive the wording is.Details of issuance or disposal
Partial exercise of the 14th Series Stock Acquisition Rights through a private placement
Who receives how much192,622,220Shares
192,622,220 common shares
Ichigo Trust: 5 rights exercised in this transaction; 85 rights unexercised
The lower thin line represents the existing number of shares to which these shares will be added.
Amount of funds to be raised
Total amount paid in: ¥4,815,555,500; remaining unexercised amount: ¥81,864,443,500
Existing Shares and Increase
+4.52%Rate of increase
4,265,632,462 shares4,458,254,682Shares
4.52% (192,622,220 shares issued in this transaction / 4,265,632,462 common shares outstanding before exercise)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥25 per share. Adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 100 rights; exercised in this transaction: 5 rights; unexercised balance: 85 rights
Payment date
19 June 2026
Most recent equity financing
15 July 2025: Issuance of the 14th Series Stock Acquisition Rights (the document does not provide detailed amounts), 13 May 2026: Partial exercise of Stock Acquisition Rights by Ichigo (the document does not provide detailed amounts)
Impact on Business Performance
The Company believes that this exercise will contribute to strengthening its financial foundation for compliance with the continued-listing criteria and will make a significant contribution to the promotion of future business initiatives.
| Item | Details |
|---|---|
| Type of issuance or disposal | Partial exercise of the 14th Series Stock Acquisition Rights through a private placement |
| Number of shares to be issued or disposed of | 192,622,220 common shares |
| Amount of funds to be raised | Total amount paid in: ¥4,815,555,500; remaining unexercised amount: ¥81,864,443,500 |
| Payment date | 19 June 2026 |
| Intended allottee | Ichigo Trust: 5 rights exercised in this transaction; 85 rights unexercised |
| Dilution Rate | 4.52% (192,622,220 shares issued in this transaction / 4,265,632,462 common shares outstanding before exercise) |
| Total number of issued shares | 4,265,632,462 common shares and 5,540 Series E preferred shares → 4,458,254,682 common shares and 5,540 Class E preferred shares |
| Exercise price | ¥25 per share. Adjustment provisions and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 100 rights; exercised in this transaction: 5 rights; unexercised balance: 85 rights |
| Most recent equity financing | 15 July 2025: Issuance of the 14th Series Stock Acquisition Rights (the document does not provide detailed amounts), 13 May 2026: Partial exercise of Stock Acquisition Rights by Ichigo (the document does not provide detailed amounts) |
| Impact on Business Performance | The Company believes that this exercise will contribute to strengthening its financial foundation for compliance with the continued-listing criteria and will make a significant contribution to the promotion of future business initiatives. |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the financial foundation for compliance with the continued-listing criteria and contribute to the promotion of future business initiatives.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.